AKR1C1 Antikörper (AA 1-323)
Kurzübersicht für AKR1C1 Antikörper (AA 1-323) (ABIN5776092)
Target
Alle AKR1C1 (DDH) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-323
-
Verwendungszweck
- Human Aldo-keto Reductase 1C1/AKR1C1 antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human AKR1C1 (1-323aa) purified from E. coli
-
Isotyp
- IgG1 kappa
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- AKR1C1 (DDH) (Dihydrodiol Dehydrogenase (DDH))
-
Andere Bezeichnung
- Aldo-keto Reductase 1C1/AKR1C1
-
Hintergrund
- The human aldo-keto reductases 1C1 and 1C3 (AKR1C1 and AKR1C3) have major roles in pre receptor regulation of progesterone action. They can both convert progesterone to the less potent efficiencies. AKR1C1 and AKR1C3 also act as 3-ketosteroid reductase, and as such they can convert the most potent androgen 5alpha-DHT into 3beta-andorstandiol, which is an estrogen receptor beta ligand, and into the inactive androgen 3alpha-androstnionl, respectively.
-
NCBI Accession
- NP_001344
-
Pathways
- Steroid Hormone Biosynthesis, C21-Steroid Hormone Metabolic Process
Target
-